Hemorrhage, Gastrointestinal Active Not Recruiting Phase 3 Trials for Erythromycin (DB00199)

Also known as: GI hemorrhage / G.I. hemorrhage / G.I. bleeding / Gastrointestinal haemorrhages / Gastrointestinal haemorrhage / Gastrointestinal Hemorrhage / Gastro intestinal bleeding / GI bleeding / Hemorrhage gastrointestinal / Gastric hemorrhage NOS / Gastrointestinal bleeding / Gastrointestinal tract bleed (NOS) / Gastrointestinal tract bleed NOS / GI haemorrhage / Haemorrhage gastrointestinal / GI bleed / Gastrointestinal haemorrhage NOS / Gastro-intestinal tract bleed / Haemorrhage of digestive tract / Haemorrhage of gastrointestinal tract, unspecified / Hemorrhage of gastrointestinal tract, unspecified / Gastro intestinal bleed / Bleeding gastrointestinal / Gastrointestinal bleed / GI tract bleed / Hemorrhage of digestive tract

IndicationStatusPhase
DBCOND0085396 (Hemorrhage, Gastrointestinal)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01716572Erythromycin Versus Gastric Lavage to Improve Quality of Endoscopy in Patients With Upper Gastrointestinal BleedingTreatment